See also this year's filing and all EDGAR filings for this company.
PDF Report 0001113148_2023_Infinity_Pharmaceuticals_INC.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
Graph
Absolute values for 0001113148, Infinity Pharmaceuticals INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 40,302,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 800,000 |
| 3 | remainder_Assets | 1,049,000 |
| 4 | LiabilitiesCurrent | 13,628,000 |
| 5 | LiabilitiesNoncurrent | 361,000 |
| 6 | remainder_Liabilities | 47,213,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 13,299,444 |
| 9 | ResearchAndDevelopmentExpense | 32,579,817 |
| 10 | remainder_Expenses | 1,426,781 |
| 11 | remainder_Revenues | 2,355,043 |
| 12 | remainder_NetIncome | 277,243 |
| 13 | remainder_ComprehensiveNetIncome | 65.0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 42,151,000 |
| 1 | Liabilities | 61,202,000 |
| 2 | Expenses | 47,306,042 |
| 3 | Revenues | 2,355,043 |
| 4 | StockholdersEquity | -19,051,000 |
| 5 | NetIncome | -44,673,756 |
| 6 | ComprehensiveNetIncome | -44,673,724 |
| 7 | BaseVar | 76,645,696 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | -1.67 |
| 9 | EconomicCapitalRatio | 1.13 |
Edgar->Model Mapping
Feature Distribution
Change over Time
